share_log

Chemomab Therapeutics Granted 180-Day Extension By Nasdaq To Regain Compliance With Minimum Bid Price Rule

Chemomab Therapeutics Granted 180-Day Extension By Nasdaq To Regain Compliance With Minimum Bid Price Rule

纳斯达克批准Chemomab Therapeutics延期180天,以恢复对最低出价规则的遵守
Benzinga ·  05/08 07:15

Chemomab Therapeutics Granted 180-Day Extension By Nasdaq To Regain Compliance With Minimum Bid Price Rule

纳斯达克批准Chemomab Therapeutics延期180天,以恢复对最低出价规则的遵守

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发